The three-state illness-death model provides a useful way to characterize data from a rodent tumorigenicity experiment.
Introduction
Rodent tumorigenicity experiments play an important role in evaluating the carcinogenic potential of pesticides, food additives, and drugs. A standard experiment involves about 600 animals ofboth sexes in each oftwo strains randomized to a control group or one of two or three exposed groups. Animals are observed over an average lifetime of 18-24 months with the goal of comparing dose groups with respect to tumor development.
It is now well known that time-adjusted statistical analyses are desirable due to toxic effects ofthe high experimental dose levels typically used (1) . Such analyses are complicated, however, by the fact that tumors are detectable only at the time of death. Appropriate methods are available if one assumes that tumors are either nonlethal (2) or instantly lethal (1) . However, most tumors are of intermediate lethality, in which case alternative methods ofanalysis are needed. In recent years, many authors have turned to methods based on fitting the three-state illness-death model depicted in Figure 1 . The quantity ofinterest is X(t z), the tumor incidence rate at time t for an animal exposed at dose level z (3) . The functions a and represent the instantaneous death rates at time t, with and without tumor, respectively. Note that, in general, the rate ofdeath with tumor may also depend on the time ofonset (x). While all ofthe methods proposed in the literature have in common the objective of characterizing or testing for a dose effect on X(t z), they vary considerably in the type ofparametrization used; and there has been relatively little discussion regarding the similarities and differences among the various methods available.
The most straightforward approach is to assume that the functions characterizing the transition rates in the three-state process follow some fully specified parametric form (4, 5) . To relax the need for strong parametric constraints, Borgan et al. (6) propose the use ofpiecewise exponential models, claiming that these are only loosely parametric if enough change points are allowed. Most of the proposals in the literature, however, formulate the problem in discrete time, arguing in analogy to standard survival analysis that the results are fully nonparametric (3, (7) (8) (9) . In a variation ofthis approach, Dinse (10) suggests the use ofa mixedtime formulation where the death process is modeled in discrete time and tumor onset in continuous time. In practice, the approaches using discrete time end up imposing coarse grouping ofthe data because the number ofallowable distinct death times is limited by the number of sacrifices in the experiment.
To avoid the limitation of requiring one sacrifice per interval, Portier (11 ) and Portier and Dinse (12) suggest the use of semiparametric models that place parametric restrictions on the tumor incidence function, but use a nonparametric discrete-time parametrization on the death process. Recently, Dinse (13) (20) can be applied because death (the censoring mechanism) is independent of the event of interest (tumor onset). It will be seen that the mixed-time formulation is the same as the grouped data survival parametrization described by Kalbfleisch and Prentice (21 A(x) = Aj for rj, < x < j d (t) = Pj for r1< t < trj a(t) = j3ee for Tj-l < t < rj.
Discrete Time
Under the discrete-time model, the hazards in Figure 1 correspond to the probability offailing at a particular time given survival to that time:
P= Pr(T= rj iT rj, 6 = 1)
where the relationship between acx and UP is based on the Kalbfleisch and Prentice (21 ) grouped data parametrization and is used to ensure comparability of 0 among the three models.
Mixed Time
Dinse's (13) mixed-time model assumes deaths occur in discrete-time with hazards defined exactly as for the discrete-time model above:
Unlike the discrete-time formulation, however, tumors are assumed to occur in continuous time, so that the likelihood involves the following conditional probabilities that a tumor developed within the interval, given that no tumor had developed as of the beginning of the interval:
Fitting the Models Four types ofevents are possible at any observed event time: death, no tumor (DNT); death with tumor (DWT); sacrifice, no tumor (SNT); and sacrifice with tumor (SWT). The likelihood contributions of these events for all three models are shown in detail in Appendix A. For each formulation, the likelihood contributions ofanimals with tumor involve integrals or sums over the tumor onset distribution which make the observed data likelihood difficult to work with directly.
The EM algorithm provides a useful alternative to maximizing the observed data likelihood for all three models and also facilitates comparison of the models. The complete data likelihood is calculated assuming exact times to tumor are known in the piecewise continuous model and assuming the intervals of onset are known in the discrete and mixed models. The E step of the EM algorithm involves finding the expected values of the complete data sufficient statistics conditional on the observed data (Y) and assuming the current parameter estimates (i). The complete data likelihood is then maximized (the M step) and the steps repeated until the parameter estimates converge.
Complete Data Log Likelihoods
The complete data log likelihoods are based on observed data, as well as on the imputed sufficient statistics from the unobservable data. The observed data in each oftheJintervals consists of counts ofanimals experiencing one ofthe four possible events. Let aj and mj be the number of animals dying or sacrificed without tumor, and bj and nj be the number dying or sacrificed with tumor in the j ' interval. Let the number of animals still alive at the beginning ofeach interval be denoted by Rj. Under the discrete-time model:
The mixed-time model leads to the complete data likelihood:
The log likelihoods under the continuous-and mixed-time models have the attractive feature of splitting into two pieces that can be maximized independently. The continuous-time model is particularly simple because software already exists to maximize piecewise exponential survival models. Alternatively, iterative, weighted least squares or a Newton-Raphson algorithm can be easily programmed in a matrix language. Even within an EM framework, maximizing the discrete time log likelihood is cumbersome and requires a Newton-Raphson algorithm with complicated derivatives. Because the baseline hazards in the discrete-and mixed-time models are required to lie between 0 and 1, constrained maximization techniques are advisable for these two models.
By examining the solutions to the complete data log likelihoods, one can see that differences among the three approaches can largely be explained by their differing assumptions about how events are distributed within the intervals in which they occur. To see this more clearly, consider the maximum likelihood estimates for the baseline tumor onset rates in thej ' interval: 
Expectation Steps
In all three models, the E step involves calculation of the expected number of tumor onsets in intervalj, Nj:
where pj(ti) is the conditional probability that an animal acquired its tumor in interval Ij given it died or was sacrificed with tumor at ti. The precise form of pj(ti) differs for the three models and is given in Appendix B. In all three cases, ofcourse, pj(ti) equals zero for all intervals after the one in which t, falls.
The continuous-time model requires the additional calculation of the expected times at risk with and without tumor, 7/ and 7jT'
Expressions for these quantities are also given in Appendix B.
Adding Covariates
For each model, covariates can easily be added to the hazards for death and tumor onset. To allow for a dose effect on tumor onset, for example, a proportional hazards assumption can be placed on X:
A(tz) -A(t)elz, where Z indicates exposure group. Using the Kalbfleisch and Prentice (I) parametrization,
for the mixed and discrete models maintain comparability of^t' across the three models.
Similarly, covariates can be added to the death hazard with no tumor to account for toxic effects ofthe carcinogen. Hazards for death in the continuous-time model are then: 6(t, z) = P(t)ePz a(t, z) = ,6(t)eG+P.
In general, tests of hypothesis are most easily computed using likelihood ratio tests.
Some Special Cases Nonlethal Tumors
When 0 = 0, the three-state model can be thought ofas a standard interval-censoring problem with death as the censoring mechanism being independent oftumor incidence, the event of interest. Animals observed to die with tumor are left-censored (0,t), and those dying without tumor are right-censored (t, oo ).
The observed data likelihoods for the continuous-and mixedtime models factor into two independent pieces, one involving only tumor onset parameters and the other, death parameters. The death (censoring) process is noninformative, and standard methods for interval-censored data can be used on the likelihood for tumor onset. The discrete time likelihood does not factor and so has no analogue in standard survival analysis.
Under the mixed-time model, the hazards for death cancel from the E step of the EM algorithm, and the resulting estimation corresponds to fitting the grouped data proportional hazards model suggested by Kalbfleisch and Prentice (21 ) and extended by Prentice and Gloeckler (23) . The mixed-time formulation that allows for tumor lethality is thus an extension ofthe grouped-data survival problem. Prentice and Gloeckler (23) require that censored individuals (deaths in the rodent context) be removed at fixed points in an interval, e.g., at the midpoint or at the end. Analogously, the mixed-time model assumes that deaths occur at the end of intervals.
One Interval
In general, testing for dose effects is most easily done using likelihood ratio tests. However, it is useful to consider the score test for dose effects in the simple case ofone interval (J = 1). For both the mixed-and discrete-time models, the score test can be shown to take the following form:
where p denotes the proportion of animals allocated to the exposed group, and subscripts refer to the number ofanimals in the exposed group. This is nothing other than the lifetime incidence test based on total tumor counts. The score test in the continuoustime model is:
It is based on expected times at risk with no tumor and uses information about the death times ofthe animals. This extreme example illustrates one ofthe important benefits ofthe continuoustime model over the other two. This point will be further illustrated with the examples in the next section.
Application: ED01 Data
The EDO1 experiment was conducted at the National Center for Toxicological Research, and involved 24,000 female mice ran- 1  3  0  0  2  0  1  0  3  2  0  0  5  0  3  0  8  0  1  0  9  1  0  0  10  0  0  22  12  1  1  0  13  0  1  19  14  2  2  19  15  0  2  0   16  0  3  12  17  2  3  12   18  0  1  11  19  1  1  64   20  1  3  0  21  1  1  0  22  0  2  0   23  0  1  0  24  0  1  0  25  0  3  0  27  0  3  0  28 domized to either a control group or one of seven dose levels of months. We will examine a subset of data from one room conthe known carcinogen 2-acetylaminofluorene (AAF) (24) . There sidering control and high-dose groups only. Results are reported were eight interim sacrifice times, and a terminal sacrifice at 33 on bladder and lung tumors from 671 animals. It is known that (24) . The data are summarized by month in Tables  1 and 2 , where numbers of deaths and sacrifices with and without tumor are shown. Note that the bladder tumor incidence rate in the control group is low compared to lung tumor incidence but that many more bladder tumors occur in the high-dose group. 
Conclusions
The relationship of the three modeling assumptions becomes clear after looking at the complete data likelihoods and their maximum likelihood estimators. The continuous-time model will reduce to either the discrete or mixed models when assumptions are made about when deaths, sacrifices, and tumors can occur during an interval.
When tumors are nonlethal, the models reduce to a simple survival analysis with interval censoring on tumor onset. The mixed model is seen to be an extension ofthe grouped data parametrization ofKalbfleisch and Prentice (21) . The continuous piecewise model reduces to the usual parametric case, but the discrete-time model has no analogue in this context.
Looking at the single-interval case, the test for dose effects in the mixed-and discrete-time models reduce to the well-known lifetime incidence test. The continuous-time model incorporates expected times of tumor onset based on the lifetime of the animals and is less likely to be biased than the discrete-or mixedtime model tests when compounds are toxic. Further exploration ofthe bias and relative efficiency ofthe estimates using simulation techniques would be useful.
In summary, the results of this paper suggest that the continuous-time model has several advantages over the discreteand mixed-time models. Like the discrete-time models, it imposes only a weakly parametric (6) structure on the underlying hazards for death and tumor onset. Although it is slightly more computationally intensive (it requires the calculation of expected times at risk without tumor), the continuous-time model does not require the use ofconstrained maximization techniques, as there are no upper limits on the ranges ofthe parameters. Because the continuous model uses information about exact death times, the placement of deaths and sacrifices at interval boundaries required by the mixed-time and discrete-time models need not be made. Realistic estimates of the underlying hazards can be obtained with relatively few intervals which, when chosen aprior, allow the application of standard likelihood theory.
Appendix A Observed Data Likelihoods
Suppose the death time t -for the io animal falls in Ij. Then under the three different models, the likelihood contributions for death with and without tumor can be written as follows: Ej(x t,) is the same for naturally dying and sacrificed animals and is the expected time without tumor contributed to thejfth interval given tumor onset in that interval.
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